Literature DB >> 27032564

FITC-Dextran entrapped and silica coated gadolinium oxide nanoparticles for synchronous optical and magnetic resonance imaging applications.

Shailja Kumar1, Virendra Kumar Meena2, Puja Panwar Hazari3, Rakesh Kumar Sharma4.   

Abstract

We report, microemulsion mediated synthesis of FITC-dextran dye entrapped and silica coated Gd2O3 nanoparticles (NPs) for dual purpose of optical and magnetic resonance imaging, in the present study. TEM image revealed that the average size of the NPs is 18nm and hydrodynamic diameter of the particles as measured by DLS comes out to be about 16nm. Gd2O3 core show paramagnetism which is affirmed by the NMR line broadening effect on neighboring water proton spectrum and also by magnetization curve obtained in VSM analysis. The fluorescence of the entrapped dye is confirmed by the UV-vis and fluorescence spectroscopy. Nanoencapsulation of FITC-dextran fluorophore was found to increase its optical activity and provided a blanket against quenching. Moreover, TGA data revealed that entrapment of dye imparts thermal stability to it and enhances its fluorescence in comparison to bare dye. The release kinetic pattern (at pH 7.4) of the entrapped dye revealed that these particles behave as non-releasing system. The in-vitro cell viability (SRB) assay of the particles done on normal cell line (HEK-293) as well as cancerous cell line (A-549) indicated non-cytotoxic nature of the particles. In a nut-shell, these particles have the potential to be efficiently used for optical and magnetic resonance imaging. We anticipate that further optimization of these particles can be done by either conjugating or entrapping a drug for targeted drug delivery which would open more prospective options in biomedical field.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Contrast agent; FITC-dextran; Gadolinium oxide nanoparticles; Optical imaging

Mesh:

Substances:

Year:  2016        PMID: 27032564     DOI: 10.1016/j.ijpharm.2016.03.040

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies.

Authors:  Tohid Mortezazadeh; Elham Gholibegloo; Nader Riyahi Alam; Sadegh Dehghani; Soheila Haghgoo; Hossein Ghanaati; Mehdi Khoobi
Journal:  MAGMA       Date:  2019-02-07       Impact factor: 2.310

2.  Enhanced biosafety of silica coated gadolinium based nanoparticles.

Authors:  Marta Laranjeira; Yuki Shirosaki; Saki Yoshimatsu Yasutomi; Toshiki Miyazaki; Fernando Jorge Monteiro
Journal:  J Mater Sci Mater Med       Date:  2017-02-04       Impact factor: 3.896

3.  Enhanced alveo pulmonary deposition of nebulized ciclesonide for attenuating airways inflammations: a strategy to overcome metered dose inhaler drawbacks.

Authors:  Hanan M El-Laithy; Amal Youssef; Shereen S El-Husseney; Nesrine S El Sayed; Ahmed Maher
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

4.  Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer.

Authors:  Danting Cui; Xiaodan Lu; Chenggong Yan; Xiang Liu; Meirong Hou; Qi Xia; Yikai Xu; Ruiyuan Liu
Journal:  Int J Nanomedicine       Date:  2017-09-12

5.  Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI.

Authors:  Mortezazadeh T; Gholibegloo E; Riyahi Alam N; Haghgoo S; Musa A E; Khoobi M
Journal:  J Biomed Phys Eng       Date:  2020-02-01

6.  Anti-Angiogenic and Anti-Proliferative Graphene Oxide Nanosheets for Tumor Cell Therapy.

Authors:  Valeria Verde; Anna Longo; Lorena Maria Cucci; Vanessa Sanfilippo; Antonio Magrì; Cristina Satriano; Carmelina Daniela Anfuso; Gabriella Lupo; Diego La Mendola
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.